Ion paclitaxel-eluting coronary stent regulatory update

FDA approved the Ion and Taxus Liberte paclitaxel-eluting coronary stent systems from Boston Scientific to treat acute myocardial infarction. Both are next-generation drug-eluting coronary platinum ch...